RecallDepth
Class II Terminated

Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06), Mfg: Amneal Pharmaceuticals

Company
Preferred Pharmaceuticals, Inc.
Recall Initiated
December 2, 2019
Posted
December 18, 2019
Recall Number
D-0617-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
316 bottles
Firm Location
Anaheim, CA, United States

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Distribution

CA, FL

Lot / Code Info

Lot #: I2519H, Exp. 12/20; I2719O, Exp. 12/20; J1419O, Exp. 12/20; J2819L, Exp. 12/20

More recalls by Preferred Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls